Copyright
©The Author(s) 2017.
World J Cardiol. Sep 26, 2017; 9(9): 731-736
Published online Sep 26, 2017. doi: 10.4330/wjc.v9.i9.731
Published online Sep 26, 2017. doi: 10.4330/wjc.v9.i9.731
Ref. | Study population | Study design | Outcome measures | Relationship with obesity |
Akin et al[2] | 1436 normal weight, 2839 overweight, and 1531 obese patients | Retrospective Cohort Study | Primary endpoints were the rate of major adverse cardiac and cerebrovascular events and target vessel revascularization | Baseline clinical parameters were more severe in overweight and obese patients |
Angerås et al[15] | 64436 patients going under angiography. Patients were divided into 9 groups based upon BMI | Cohort Study | To investigate the relationship between BMI and mortality in patients with ACSs | Obese and overweight patients have least mortality compared with normal, underweight, and morbidly obese patients |
Gurm et al[14] | 4 randomized, controlled trials | Systematic Review | To study the impact of BMI on outcome patients undergoing PCI | Increased BMI is associated with reduced risk of complications after PCI |
Kaneko et al[11] | 1205 patients: 92 lean, 640 normal-weight; 417 overweight, and 56 obese | Retrospective Cohort Study | Impact of obesity on Japanese patients who undergo primary PCI | Over-weight and obese patients were independently associated with favorable long-term clinical outcomes after PCI |
Lazzeri et al[17] | 1268 patients: 37 lean, 403 normal, 656 overweight, 172 obese patients | Case Series | Impact of age on the prognostic value of BMI | In patients < 75 yr, overweight patients showed increased in-hospital mortality rate and a poorer long-term survival rate |
Kosuge et al[20] | 3076 patients undergoing PCI | Case Control Study | In-hospital mortality | BMI itself had no impact on in-hospital mortality in patients undergoing primary PCI |
Sharma et al[19] | 36 studies (12 CABG; 26 PCI) | Meta-Analysis | Total mortality, CV mortality, and myocardial infarction | The risk of total mortality, CV mortality, and MI was highest among underweight patients as defined by low BMI and CV mortality was lowest among overweight patients |
Stähli et al[9] | 1993 patients: 461 (23.1%) were of normal weight, 985 (49.4%) overweight, 396 (19.9%) obese, and 144 (7.2%) very obese | Retrospective Cohort Study | All-cause mortality | Overweight and obese patients had lower all-cause mortality |
Lancefield et al[10] | 4762 patients undergoing PCI | Meta-Analysis | In-hospital and 12-mo MACE and mortality rates after PCI | Overweight and obese patients had lower in-hospital and 12-mo MACE and mortality rates after PCI |
Uretsky et al[5] | 22576 hypertensive patients with coronary artery disease | Randomized Control Trial | Primary outcomes include first occurrence of death, nonfatal myocardial infarction, or nonfatal stroke | Obese patients had a decreased risk of primary outcomes |
Kang et al[12] | 3824 STEMI patients: 129 underweight, 1253 normal weight, 1959 overweight, 483 obese | Retrospective Cohort Study | In-hospital mortality, revascularization in 1 yr, mortality in 1 yr, and overall mortality | Obese patients had significantly lower in-hospital and overall mortalities |
Numasawa et al[13] | 10142 patients: 462 underweight, 5945 normal, 3100 overweight and 635 obese | Retrospective Cohort Study | In-hospital outcomes | Obese patients are at a lower risk for in-hospital complications during and after PCI |
Younge et al[16] | 1019 patients: 354 normal, 468 overweight, and 197 obese | Prospective Cohort Study | All-cause mortality | Overweight, but not obesity, was associated with a lower risk for 7-yr mortality in PCI patients |
Wang et al[21] | 6083 patients (normal: 1592; overweight: 3026; obese: 1465) | Retrospective Cohort Study | Clinical-driven repeat revascularization, including TLR and non-TLR | Obesity was not associated with TLR, but was associated with a higher risk of non-TLR |
- Citation: Patel N, Elsaid O, Shenoy A, Sharma A, McFarlane SI. Obesity paradox in patients undergoing coronary intervention: A review. World J Cardiol 2017; 9(9): 731-736
- URL: https://www.wjgnet.com/1949-8462/full/v9/i9/731.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i9.731